Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nautilus Biotechnology (NAUT) Consolidated Net Income (2020 - 2021)

Nautilus Biotechnology has reported Consolidated Net Income over the past 2 years, most recently at -$1.8 million for Q1 2021.

  • Quarterly results put Consolidated Net Income at -$1.8 million for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was -$1.8 million (changed N/A YoY), and the annual figure for FY2020 was -$576035.0, changed.
  • Consolidated Net Income reached -$1.8 million in Q1 2021 per NAUT's latest filing, down from -$576035.0 in the prior quarter.
  • Across five years, Consolidated Net Income topped out at -$174671.0 in Q3 2020 and bottomed at -$1.8 million in Q1 2021.